Bio Port Korea Inc. (KOSDAQ:188040)
South Korea · Delayed Price · Currency is KRW 5,100.00
-60.00 (-1.16%)
At close: Sep 1, 2026
Bio Port Korea Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
| 77,975 | 70,880 | 73,346 | 68,699 | |
Revenue Growth | 7.37% | -3.36% | 6.77% | - |
Cost of Revenue | 58,542 | 53,560 | 52,411 | 49,616 |
Gross Profit | 19,433 | 17,320 | 20,936 | 19,083 |
Selling, General & Admin | 15,060 | 14,676 | 14,515 | 13,179 |
Research & Development | 721.52 | 699.67 | 504.95 | 457.61 |
Amortization of Goodwill & Intangibles | 31.54 | 31.75 | 9.48 | 9.48 |
Other Operating Expenses | 220.44 | 217.85 | 163.69 | 133.25 |
Operating Expenses | 17,039 | 16,490 | 15,696 | 14,164 |
Operating Income | 2,394 | 830.05 | 5,240 | 4,919 |
Interest Expense | -248.42 | -310.25 | -1,512 | -2,108 |
Interest & Investment Income | 592.57 | 557.66 | 517.44 | 408.99 |
Currency Exchange Gain (Loss) | 445.22 | -118.92 | 544.78 | 206.96 |
Other Non Operating Income (Expenses) | -366.8 | -2,808 | 1,467 | 182.24 |
EBT Excluding Unusual Items | 2,817 | -1,849 | 6,258 | 3,609 |
Gain (Loss) on Sale of Investments | - | - | 18.23 | -13.91 |
Gain (Loss) on Sale of Assets | -61.47 | - | -924.59 | - |
Pretax Income | 2,755 | -1,849 | 5,352 | 3,595 |
Income Tax Expense | -207.44 | -445.57 | 1,240 | 225.62 |
Net Income | 2,963 | -1,403 | 4,112 | 3,369 |
Net Income to Common | 2,963 | -1,403 | 4,112 | 3,369 |
Net Income Growth | 359.87% | - | 22.04% | - |
Shares Outstanding (Basic) | 5 | 4 | 3 | 3 |
Shares Outstanding (Diluted) | 5 | 4 | 4 | 4 |
Shares Change | 6.36% | 16.68% | 1.04% | - |
EPS (Basic) | 654.00 | -336.14 | 1465.53 | 1347.75 |
EPS (Diluted) | 654.00 | -336.14 | 1438.99 | 1302.58 |
EPS Growth | 253.96% | - | 10.47% | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
Free Cash Flow | -6,479 | 2,486 | 8,491 | -1,253 |
Free Cash Flow Per Share | -1430.31 | 595.53 | 2372.83 | -353.75 |
Gross Margin | 24.92% | 24.44% | 28.54% | 27.78% |
Operating Margin | 3.07% | 1.17% | 7.14% | 7.16% |
Profit Margin | 3.80% | -1.98% | 5.61% | 4.91% |
Free Cash Flow Margin | -8.31% | 3.51% | 11.58% | -1.82% |
EBITDA | 4,994 | 3,209 | 7,102 | 6,328 |
EBITDA Margin | 6.40% | 4.53% | 9.68% | 9.21% |
D&A For EBITDA | 2,600 | 2,378 | 1,862 | 1,409 |
EBIT | 2,394 | 830.05 | 5,240 | 4,919 |
EBIT Margin | 3.07% | 1.17% | 7.14% | 7.16% |
Effective Tax Rate | - | - | 23.16% | 6.28% |
Advertising Expenses | - | 542.08 | 966.01 | 768.83 |